期刊文献+

GST-π和LRP在胃癌中的表达及其临床意义 被引量:3

Clinical Significance and Expression of GST-π and LRP in Gastric Carcinoma
下载PDF
导出
摘要 目的:探讨谷胱甘肽转移酶(GST-π)和肺耐药蛋白(LRP)在胃癌中的表达及其临床意义。方法:应用免疫组化法检测GST-π和LRP在80例胃癌组织和20例正常胃粘膜组织中的表达,探讨胃癌组织学类型、肿瘤浸润深度及有无淋巴结转移对GST-π和LRP表达的影响。结果:GST-π和LRP在胃癌组织中的阳性表达率高于正常胃粘膜组织(P<0.05);在高中分化腺癌中的表达显著高于低分化腺癌(P<0.05);在浸润粘膜及粘膜下层组、肌层组、浆膜及浆膜外组表达率无显著差别(P>0.05);在有淋巴结转移组GST-π、LRP表达率显著高于无淋巴结转移组(P<0.05)。结论:GST-π、LRP在胃癌原发性多药耐药中起重要作用,其表达与组织学类型、有无淋巴结转移有关,而与肿瘤浸润深度无关,联合检测GST-π、LRP对于胃癌判断预后、制定化疗方案有一定的指导意义。 Objective: To study the clinical significance and expression of glutathione-s-trannsferase(GST-π) and lung resistance protein(LRP) in gastric carcinoma tissue.Method: The expression of GST-πand LRP in 80 cases of Gastric carcinoma and 20 cases of normal stomach tissues were detected by immunohistochemical technique,its correlation with clinical pathologic characteristic of gastric carcinoma,including histological type,invasion degree and lymph node metastasis,were explored.Result: The positive expression rates of GST-π and LRP in gastric carcinoma were all higher than those in normal stomach tissues(P〈0.05).The expression rates of GST-π and LRP in well-moderated differentiated adenocarcinoma were significantly higher than those in poor differentiated adenocarcinoma(P〈0.05).There was no significant difference between the expression rates of GST-π and LRP in the three groups which invading mucoma and submocuma,invading musculairs and invading serosa and beyond serosa(P〉0.05).The expression rates of GST-π and LRP in tissues with lymph metastasis were significantly higher than in those without lymph node metastasis(P〈0.05).Conclusion: GST-π and LRP play important roles in the primary multidrug resistance(MDR)of gastric carcinoma.The expression of them is associated with histological type and lymph node metaaastasis,while not associated with invased layer.The determination of GST-πand LRP may be useful for the estimatation of prognosis and the establishment of chemical therapy regimen in gastric carcinoma.
出处 《河北医学》 CAS 2007年第7期766-769,共4页 Hebei Medicine
关键词 胃癌 谷胱甘肽S转移酶 肺耐药蛋白 多药耐药 Gastric carcinoma Glutathione-s-trannsferase(GST-π) Lung resistance protein(LRP) Multidrug resistance(MDR)
  • 相关文献

参考文献13

  • 1孙燕.肿瘤内科学[M].北京:人民卫生出版社,2001.450-451.
  • 2Kaye SB.Clinical drug resistance:the role of factors other than P-glycoprotein[J].Am Med,1995,9:40-51.
  • 3Harrison DJ.Molecular mechanisms of drug resistance in tumors[J].Pathol,1995,175:7-14.
  • 4Woodhouse JR.The genetic basis of resistance to cancer chemotherapy[J].Ann Med,1995,27:157-164.
  • 5易晓芳,丰有吉.肿瘤多药耐药机制的研究[J].中国实用妇科与产科杂志,2004,20(3):185-187. 被引量:9
  • 6Labialle S,Gayet L,Marthinet E,et al.Transcriptional regulators of the human multidrug resistance 1 gene:recent views[J].Biochem Pharmacol,2002,64:943 -938.
  • 7Borst P,Evers R.A family of drug transporters:the multidrug resistance associated proteins[J].Natl Cancer Inst,2000,92:1295-1302.
  • 8Mechetner EB.Efficient inhibitor of P-glycoprotein mediated multidrug resistance with a monoclonal antibody[J].Proc Natl Acad Sci USA,1992,89:58245831.
  • 9Arsenault AL.Altered plasma menbrane ultrastructure in multidrug -resistant cells[J].Biochim Biophys Acta,1988,938:315-321.
  • 10Scheper RJ.Overexpression of a Mr 110000 Vesicular protein innon-P-glycoprotein mediated multidrug resistance[J].Cancer Res,1993,53:1475-1481.

二级参考文献26

  • 1[1]Biedler JL,Riehm H.Cellular resistance to actinomycin D in Chinese hamster cells in vitro:cross-resistance,radioautographic,and cytogenetic studies.Cancer Res,1970,30(4):1174-1184
  • 2[2]Higgins CF.ABC transporters:from microorganisms to man.Ann Rev Cell Biol,1992,8:67-113
  • 3[3]Juliano RL,Ling V.A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants.Biochem Biophys Acta,1976,455(1:152-162
  • 4[4]Labialle S,Gayet L,Marthinet E,et al.Transcriptional regulators of the human multidrug resistance Ⅰ gene:recent views.Biochem Pharmacol,2002,64(5-6):943-938
  • 5[5]Stein WD.Kinetics of the multidrug transporter (P-glycoprotein) and its reversal.Physiol Rev,1997,77(2:545-590
  • 6[6]Hipfner DR,Deeley RG,Cole SP.Structural,mechanistic,and clinical aspects of MRP1.Biochem Biophys Acta,1999,1461(2:359-376
  • 7[7]Borst P,Evers R,Kool M,et al.A family of drug transporters:the multidrug resistance-associated proteins.J Natl Cancer Inst,2000,92(6):1295-1302
  • 8[8]Scheper RJ,Broxterman HJ,Scheffer GL,et al.Overexpression of a M(r) 110000 vesicular protein in non-P-glycoprotein-mediated multidrug resistance.Cancer Res,1993,53(7):1475-1479
  • 9[9]Chen YN,Mickley LA,Schwartz AM,et al.Characterization of adriamycin-resistant human breast cancer cells which display overexpression of a novel resistance-related membrane protein.J Biol Chem,1990,265(17):10073-10080
  • 10[10]Lee JS,Scala S,Matsumoto Y,et al.Reduced drug accumulation and multidrug resistance in human breast cancer cells without associated P-glycoprotein or MRP overexpression.J Cell Biochem,1997,65(4):513-526

共引文献88

同被引文献18

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部